No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
Neutron spectra and dose equivalents calculated in tissue for high-energy radiation therapy
1.National Council on Radiation Protection and Measurements, “Neutron contamination from medical electron accelerators,” Report No. 79. National Council on Radiation Protection and Measurements, Bethesda, MD, 1984.
2.R. Nath, A. Boyer, P. D. LaRiviere, R. C. McCall, and K. W. Price, “Neutron measurements around high energy X-ray radiotherapy machines. A Report of Task Group 27, Radiation Therapy Committee, American Association of Physicists in Medicine,” AAPM Report No. 19. Medical Physics Publishing, NY, 1986.
3.X. S. Mao, K. R. Kase, J. C. Liu, W. R. Nelson, J. H. Kleck, and S. Johnsen, “Neutron sources in the Varian Clinac 2100C/2300C medical accelerator calculated by the EGS4 code,” Health Phys. 72, 524–529 (1997).
4.S. F. Kry, R. M. Howell, U. Titt, M. Salehpour, R. Mohan, and O. N. Vassiliev, “Energy spectra, sources, and shielding considerations for neutrons generated by a flattening filter-free accelerator,” Med. Phys. 35, 1906–1911 (2008).
5.S. F. Kry, M. Salehpour, D. Followill, M. Stovall, D. Kuban, R. A. White, and I. Rosen, “Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy,” Int. J. Radiat. Oncol., Biol., Phys. 62, 1204–1216 (2005).
6.R. M. Howell, M. S. Ferenci, N. E. Hertel, G. D. Fullerton, T. Fox, and L. W. Davis, “Measurements of secondary neutron dose from 15 MV and 18 MV IMRT,” Radiat. Prot. Dosim. 115, 508–512 (2005).
7.R. M. Howell, N. E. Hertel, Z. Wang, J. Hutchinson, and G. D. Fullerton, “Calculation of effective dose from measurements of secondary neutron spectra and scattered photon dose from dynamic MLC IMRT for 6 MV, 15 MV, and 18 MV beam energies,” Med. Phys. 33, 360–368 (2006).
8.C. S. Reft, R. Runkel-Muller, and L. Myrianthopoulos, “In vivo and phantom measurements of the secondary photon and neutron doses for prostate patients undergoing 18 MV IMRT,” Med. Phys. 33, 3734–3742 (2006).
9.R. Barquero, T. M. Edwards, M. P. Iniguez, and H. R. Vega-Carrillo, “Monte Carlo simulation estimates of neutron doses to critical organs of a patient undergoing 18 MV x-ray LINAC-based radiotherapy,” Med. Phys. 32, 3579–3588 (2005).
11.K. R. Kase, X. S. Mao, W. R. Nelson, J. C. Liu, J. H. Kleck, and M. Elsalim, “Neutron fluence and energy spectra around the Varian Clinac 2100C/2300C medical accelerator,” Health Phys. 74, 38–47 (1998).
13.D. S. Followill, M. S. Stovall, S. F. Kry, and G. S. Ibbott, “Neutron source strength measurements for Varian, Siemens, Elekta, and General Electric linear accelerators,” J. Appl. Clin. Med. Phys. 4, 189–194 (2003).
14.F. D'Errico, R. Nath, G. Silvano, and L. Tana, “In vivo neutron dosimetry during high-energy bremsstrahlung radiotherapy,” Int. J. Radiat. Oncol., Biol., Phys. 41, 1185–1192 (1998).
15.F. D’Errico et al., “Depth dose-equivalent and effective energies of photoneutrons generated by 6–18 MV X-ray beams for radiotherapy,” Health Phys. 80, 4–11 (2001).
16.O. Chibani and C. C. Ma, “Photonuclear dose calculations for high-energy photon beams from Siemens and Varian linacs,” Med. Phys. 30, 1990–2000 (2003).
17.A. Zanini, E. Durisi, F. Fasolo, L. Visca, C. Ongaro, U. Nastasi, K. W. Burn, and J. R. M. Annand, “Neutron spectra in a tissue equivalent phantom during photon radiotherapy treatment by linacs,” Radiat. Prot. Dosim. 110, 157–160 (2004).
18.S. F. Kry, U. Titt, D. Followill, F. Pönisch, O. N. Vassiliev, R. A. White, M. Stovall, and M. Salehpour, “A Monte Carlo model for out-of-field dose calculations from high-energy photon therapy,” Med. Phys. 34, 3489–3499 (2007).
19.J. S. Hendricks et al., MCNPX, Version 2.5.e, 2004.
20.International Commission on Radiation Units and Measurements, “Tissue substitutes in radiation dosimetry and measurement,” ICRU Report No. 44. Pergamon, Oxford, 1989.
21.R. S. Caswell, J. J. Coyne, and M. L. Randolph, “Kerma factors for neutron energies below 30 MeV,” Radiat. Res. 83, 217–254 (1980).
22.B. R. L. Siebert and H. Schuhmacher, “Quality factors, ambient and personal dose equivalent for neutron, based on the new ICRU stopping power data for protons and alpha particles,” Radiat. Prot. Dosim. 58, 177–183 (1995).
23.International Commission on Radiation Units and Measurements, “Relative Biological Effectiveness (RBE), Quality Factor (Q), and Radiation Weighting Factor ,” ICRU Report No. 92. Pergamon, Oxford, 2003.
24.National Council on Radiaton Protection and Measurements, “Structural shielding design and evaluation for megavoltage X- and Gamma-ray radiotherapy facilities,” Report No. 151. National Council on Radiation Protection and Measurements, Bethesda, MD, 2005.
25.Bubble Technology Industries (personal communication).
26.R. M. Howell, S. F. Kry, D. Followill, N. E. Hertel, Z. Wang, and M. Salehpour, “Investigation of MLC effects on secondary neutron spectra for Varian, Siemens, and Elekta,” Med. Phys. 33, 2249 (2006).
Article metrics loading...
Full text loading...
Most read this month